Supported by an educational grant from Neurocrine Biosciences, Inc.

Back to all

Limitations of Traditional and Off-Label Treatments Utilized for Idiopathic Hypersomnia and Narcolepsy in Individuals with Comorbid Mental Illness

DECEMBER 12, 2023